Zenas BioPharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Zenas BioPharma, Inc. (ZBIO) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 1.26 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.26M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 667.60K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 599.67K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 525.35K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2026-06-30 | 1.26M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 667.60K shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 599.67K shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 525.35K shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 511.10K shares 10-Q · filed 2025-08-12 |